DOCSLIB.ORG

Anticancer Potential of Bioactive Peptides from Animal Sources (Review)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Anticancer Potential of Bioactive Peptides from Animal Sources (Review) ONCOLOGY REPORTS 38: 637-651, 2017 Anticancer potential of bioactive peptides from animal sources (Review) LiNghoNg WaNg1*, CHAO DONG2*, XIAN LI1, WeNyaN haN1 and XIULAN SU1 1Clinical Medicine Research Center of the affiliated hospital, inner Mongolia Medical University; 2College of Basic Medicine of Inner Mongolia Medical University, Huimin, Hohhot, Inner Mongolia 010050, P.R. China Received October 10, 2016; Accepted April 10, 2017 DOI: 10.3892/or.2017.5778 Abstract. Cancer is the most common cause of human death 3. Mechanisms of action of bioactive peptides underlying worldwide. Conventional anticancer therapies, including their anticancer effects chemotherapy and radiation, are associated with severe side 4. Summary and perspective effects and toxicities as well as low specificity. Peptides are rapidly being developed as potential anticancer agents that specifically target cancer cells and are less toxic to normal 1. Introduction tissues, thus making them a better alternative for the preven- tion and management of cancer. Recent research has focused Although the rates of death due to cancer have been continu- on anticancer peptides from natural animal sources, such ously declining for the past 2 decades in developed nations, as terrestrial mammals, marine animals, amphibians, and cancer remains a major public health threat in many parts of animal venoms. However, the mode of action by which bioac- the world (1). The incidence of cancer in the developing world tive peptides inhibit the proliferation of cancer cells remains is currently increasing. Specifically, 55% of new cases arise unclear. In this review, we present the animal sources from in developing nations, a figure that could reach 60% by 2020 which bioactive peptides with anticancer activity are derived and 70% by 2050. Worldwide, cancer also causes a substantial and discuss multiple proposed mechanisms by which these burden of economic cost and human suffering; the cost associ- peptides exert cytotoxic effects against cancer cells. ated with cancer cases worldwide was approximately US$1.16 trillion in 2010, the equivalent of >2% of the total global gross domestic product. Nevertheless, this high figure is a lower Contents bound and does not include the substantial longer-term costs to families and caregivers (2). 1. Introduction The current gold standard of care for cancer is a combination 2. Animal sources of bioactive peptides with anticancer activity of surgery, radiation therapy, and chemotherapy (3-5). However, traditional methods are associated with drawbacks, such as a lack of screening tests for early diagnosis and a lack of tumor-specific drug delivery systems. Moreover, most classical anticancer drugs Correspondence to: Professor Xiulan Su, Clinical Medicine cannot differentiate between cancerous and normal cells, thus Research Center of the Affiliated Hospital, Inner Mongolia leading to systemic toxicity and adverse side effects. Selective Medical University, 1 Tongdao North Street, Huimin, Hohhot, and more efficient new drugs are urgently needed to address Inner Mongolia 010050, P.R. China this problem. In this context, bioactive peptides are increasingly E-mail: [email protected] being considered as good drug candidates for cancer thera- peutic applications. A growing body of peptides from natural * Contributed equally animal sources has been demonstrated to possess physiological functions, such as immunomodulatory (6), antimicrobial (7), Abbreviations: ACE, angiotensin-converting enzyme; ACPB-3, antihypertensive (8), antithrombotic (9), anticancer (10), anti- anticancer bioactive peptide-3; SALF, shrimp anti-lipopolysaccharide factor; KLH, keyhole limpet hemocyanin; CTX, chlorotoxin; oxidative (11), and cholesterol-lowering activities (12). However, LAAOs, L-amino acid oxidases; Bl-LAAO, Bothrops leucurus; this review focuses on bioactive peptides from animal sources Ltc2a, latarcins 2a; Pen-2, penaeidin-2; mPTP, mitochondrial that may specifically target cancer cells and could consequently permeability transition pore; MOMP, mitochondrial outer membrane serve as anticancer agents that are less toxic to normal tissues. permeabilization; OPA1, optic atrophy1; PHB1, prohibitin 1; DAMPs, In addition, as shown in Fig. 1, bioactive peptides usually consist death-associated molecular patterns of 2-50 amino acid residues (~102-103 Da). Thus, they easily traverse or disrupt the cell membrane and result in apoptosis Key words: bioactive peptides, anticancer activity, animal sources or necrosis. Therefore, the study and modification of bioactive peptides with anticancer activity will offer new opportunities for cancer prevention and treatment. 638 WaNg et al: anticancer potential of bioactiVE peptides The objectives of this study are to 1) review the current A number of studies have reported the anticancer effects understanding of anticancer bioactive peptides derived from of milk protein-derived peptides on various cancer cells. different animal sources and 2) summarize the mechanisms of Roy et al (19) found that bovine skim milk digested with cell- action by which bioactive peptides affect cancer cells. In addi- free extract from the yeast Saccharomyces cerevisiae inhibits tion, this review highlights the potential applications of natural the proliferation of a human leukemia cell line (HL-60). Meisel animal source-derived peptides as pharmaceutical candidates and FitzGerald reported the anticancer activity of casein frac- in the auxiliary therapy of cancer. tion-derived caseinophosphopeptides (CPPs) (20), which inhibit cancer cell growth and stimulate the activity of immunocompe- 2. Animal sources of bioactive peptides with anticancer tent cells and neonatal intestinal cells. Moreover, the bacterial activity hydrolysis of casein by commercial yogurt starter cultures yields bioactive peptides that influence colon cell kineticsin vitro (21), Terrestrial mammals and by-products. Although bioactive and a yogurt fraction obtained by membrane dialysis has been peptides with anticancer activity from terrestrial mammals found to have an anti-proliferative effect on Coca-2 and IEC-6 are not well documented, one report has described four bovine mammalian intestinal cells (22). meat-derived peptides that inhibit angiotensin-converting Lactoferrin is an 80-kDa iron-binding glycoprotein that enzyme (ACE) and also exhibit anti-proliferative activity (13). belongs to the transferrin family and has a variety of biolog- Specifically, this study has demonstrated the cytotoxic effect ical functions, including antibacterial, antiviral, anticancer, of four peptides: gFHI, DFHINg, FHG, and gLSDGEWQ. anti-inflammatory, and immunomodulatory activities (23). GFHI has been found to exhibit the most potent cytotoxic Moreover, lactoferricin is a cationic peptide generated by effect on the human breast cancer cell line (MCF-7) and to the acid-pepsin hydrolysis of lactoferrin and exhibits a range decrease the viability of a stomach adenocarcinoma cell line of biological activities, including cytotoxic activity against (AGS) in a dose-dependent manner, whereas gLSDGEWQ various microorganisms (24,25) and cancer cells (26-28). significantly inhibits the proliferation of AGS cells. The major anticancer mechanisms of lactoferrin and lacto- The group of Su identified the novel anticancer bioactive ferricin include cell cycle arrest, apoptosis, anti-angiogenesis peptide-3 (ACPB-3) (14,15), which was isolated from goat effects, anti-metastasis effects, immune modulation and spleens or livers. This peptide has been found to exhibit necrosis (28). Thus, the aforementioned studies suggest that anticancer activity against a human gastric cancer cell line milk proteins are not only a nutritious part of a normal daily (BGC-823) and gastric cancer stem cells (GCSCs) in vitro diet but also have potential for the prevention and/or manage- and in vivo. Moreover, it significantly inhibits the growth ment of cancer. of BGC-823 and CD44+ cells in a dose-dependent manner, suppressing the proliferation of spheroid cell colonies and Marine animals. Bioactive peptide compounds from marine inhibiting their clone-forming capacity. In vivo, ACBP-3 alone animals have been reported to have a broad range of bioactive or in combination with cisplatin suppresses xenograft tumor properties (29-31). An increasing number of recent studies growth, and this peptide enhances the chemotherapy toler- have focused on bioactive peptides with potential anticancer ance of mice by reducing the toxicity of the treatment during activity isolated from various marine animals, such as long-term experiments (15,16). The Su group also investigated sponges, tunicates, ascidians, mollusks, fish, and other marine the anticancer activity of ACBPs in a human colorectal tumor organisms (32-35). cell line (HCT116) in vitro and in vivo (17). Specifically, treatment with ACBPs significantly inhibits HCT116 cell Fish. Fish is a popular seafood item worldwide and have been growth, enhances UV-induced apoptosis, increases the identified as a source of bioactive peptides with potential anti- expression levels of PARP and p53, and decreases the expres- cancer activities. Selected fish-derived bioactive peptides with sion of Mcl-1. Moreover, ACBPs markedly inhibit human potential anticancer activity are listed in Table I. colorectal tumor growth in a xenograft nude mouse model The potential anti-proliferative activity of hydrolysate and induce changes in the expression levels of PARP, P53, of a by-product from dark tuna muscle has been examined
Load more

Recommended publications
  • Novel Therapeutic Interventions Towards Improved Management of Septic Arthritis Jian Wang1* and Liucai Wang2
    Wang and Wang BMC Musculoskeletal Disorders (2021) 22:530 https://doi.org/10.1186/s12891-021-04383-6 REVIEW Open Access Novel therapeutic interventions towards improved management of septic arthritis Jian Wang1* and Liucai Wang2 Abstract Septic arthritis (SA) represents a medical emergency that needs immediate diagnosis and urgent treatment. Despite aggressive treatment and rapid diagnosis of the causative agent, the mortality and lifelong disability, associated with septic arthritis remain high as close to 11%. Moreover, with the rise in drug resistance, the rates of failure of conventional antibiotic therapy have also increased. Among the etiological agents frequently isolated from cases of septic arthritis, Staphylococcus aureus emerges as a dominating pathogen, and to worsen, the rise in methicillin- resistant S. aureus (MRSA) isolates in bone and joint infections is worrisome. MRSA associated cases of septic arthritis exhibit higher mortality, longer hospital stay, and higher treatment failure with poorer clinical outcomes as compared to cases caused by the sensitive strain i.e methicillin-sensitive S. aureus (MSSA). In addition to this, equal or even greater damage is imposed by the exacerbated immune response mounted by the patient’s body in a futile attempt to eradicate the bacteria. The antibiotic therapy may not be sufficient enough to control the progression of damage to the joint involved thus, adding to higher mortality and disability rates despite the prompt and timely start of treatment. This situation implies that efforts and focus towards studying/ understanding new strategies for improved management of sepsis arthritis is prudent and worth exploring. The review article aims to give a complete insight into the new therapeutic approaches studied by workers lately in this field.
    [Show full text]
  • Resistance to Host Antimicrobial Peptides Is Necessaryfor
    Proc. Nati. Acad. Sci. USA Vol. 89, pp. 11939-11943, December 1992 Genetics Resistance to host antimicrobial peptides is necessary for Salmonella virulence (transposon mutagenesis/defensin/magainin/cecropin/pathogenesis) EDUARDO A. GROISMAN*t, CARLOS PARRA-LOPEZ*, MARGARITA SALCEDO*, CRAIG J. Lippst, AND FRED HEFFRON*§ *Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110; tDepartment of Molecular Biology, Research Institute of Scripps Clinic, La Jolla, CA 92037; and §Department of Microbiology and Immunology, Oregon Health Sciences University, Portland, OR 97201 Communicated by David M. Kipnis, September 14, 1992 ABSTRACT The production of antibacterial peptides is a distinct strategies to evade killing by the phagocyte oxygen- host defense strategy used by various species, including mam- dependent and -independent mechanisms (3). mals, amphibians, and insects. Successful pathogens, such as To cause disease, Salmonella must withstand the battery of the facultative intracellular bacterium Salmonella typhimu- short peptides with antibiotic activity present in phagocytic num, have evolved resistance mechanisms to this ubiquitous cells and other tissues. One such group of peptides is the type of host defense. To identify the genes required for resis- defensins, which are abundant in the azurophilic granules of tance to host peptides, we isolated a library of 20,000 MudJ neutrophils and macrophages from rabbits, rats, guinea pigs, transposon insertion mutants of a virulent peptide-resistant S. and humans and the crypt cells of mouse intestine (4). The typhimurium strain and screened it for hypersensitivity to the importance of these peptides for host defense is underscored antimicrobial peptide protamine. Eighteen mutants had by the fact that patients with specialized granule deficiency- heightened susceptibility to protamine and 12 of them were who lack defensins-have recurrent infections (5).
    [Show full text]
  • Analysis of the Solution Structure of the Human Antibiotic Peptide Dermcidin and Its Interaction with Phospholipid Vesicles
    BMB reports Analysis of the solution structure of the human antibiotic peptide dermcidin and its interaction with phospholipid vesicles Hyun Ho Jung1, Sung-Tae Yang2, Ji-Yeong Sim1, Seungkyu Lee1, Ju Yeon Lee1, Ha Hyung Kim3, Song Yub Shin4 & Jae Il Kim1,* 1Department of Life Science, Gwangju Institute of Science and Technology, Gwangju, 2Section on Membrane Biology, Laboratory of Cellular and Molecular Biophysics, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, 3College of Pharmacy, Chung-Ang University, Seoul, 4Department of Bio-Materials, Graduate School and Department of Cellular & Molecular Medicine, School of Medicine, Chosun University, Gwangju 501-759, Korea Dermcidin is a human antibiotic peptide that is secreted by the of the modes of action of various antimicrobial peptides have sweat glands and has no homology to other known antimicro- revealed that their cationic nature contributes to their initial bial peptides. As an initial step toward understanding dermci- binding to negatively charged bacterial membranes through din’s mode of action at bacterial membranes, we used homo- electrostatic interaction, while their amphipathic structures en- nuclear and heteronuclear NMR to determine the conforma- hance peptide-lipid interactions at the water-bilayer interface, tion of the peptide in 50% trifluoroethanol solution. We found ultimately leading to cell death via pore formation or mem- that dermcidin adopts a flexible amphipathic α-helical struc- brane disintergration (9-14). ture with a helix-hinge-helix motif, which is a common molec- Dermcidin (DCD) is an antimicrobial peptide found in hu- ular fold among antimicrobial peptides. Spin-down assays of man sweat.
    [Show full text]
  • Peptides to Tackle Leishmaniasis: Current Status and Future Directions
    International Journal of Molecular Sciences Review Peptides to Tackle Leishmaniasis: Current Status and Future Directions Alberto A. Robles-Loaiza 1, Edgar A. Pinos-Tamayo 1, Bruno Mendes 2,Cátia Teixeira 3 , Cláudia Alves 3 , Paula Gomes 3 and José R. Almeida 1,* 1 Biomolecules Discovery Group, Universidad Regional Amazónica Ikiam, Tena 150150, Ecuador; [email protected] (A.A.R.-L.); [email protected] (E.A.P.-T.) 2 Departamento de Biologia Animal, Instituto de Biologia, Universidade Estadual de Campinas (UNICAMP), Campinas 13083-862, Brazil; [email protected] 3 LAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, 4169-007 Porto, Portugal; [email protected] (C.T.); [email protected] (C.A.); [email protected] (P.G.) * Correspondence: [email protected] Abstract: Peptide-based drugs are an attractive class of therapeutic agents, recently recognized by the pharmaceutical industry. These molecules are currently being used in the development of innovative therapies for diverse health conditions, including tropical diseases such as leishmaniasis. Despite its socioeconomic influence on public health, leishmaniasis remains long-neglected and categorized as a poverty-related disease, with limited treatment options. Peptides with antileishmanial effects encountered to date are a structurally heterogeneous group, which can be found in different natural sources—amphibians, reptiles, insects, bacteria, marine organisms, mammals, plants, and others—or inspired by natural toxins or proteins. This review details the biochemical and structural characteris- Citation: Robles-Loaiza, A.A.; tics of over one hundred peptides and their potential use as molecular frameworks for the design of Pinos-Tamayo, E.A.; Mendes, B.; antileishmanial drug leads.
    [Show full text]
  • Evidence Supporting an Antimicrobial Origin of Targeting Peptides to Endosymbiotic Organelles
    cells Article Evidence Supporting an Antimicrobial Origin of Targeting Peptides to Endosymbiotic Organelles Clotilde Garrido y, Oliver D. Caspari y , Yves Choquet , Francis-André Wollman and Ingrid Lafontaine * UMR7141, Institut de Biologie Physico-Chimique (CNRS/Sorbonne Université), 13 Rue Pierre et Marie Curie, 75005 Paris, France; [email protected] (C.G.); [email protected] (O.D.C.); [email protected] (Y.C.); [email protected] (F.-A.W.) * Correspondence: [email protected] These authors contributed equally to this work. y Received: 19 June 2020; Accepted: 24 July 2020; Published: 28 July 2020 Abstract: Mitochondria and chloroplasts emerged from primary endosymbiosis. Most proteins of the endosymbiont were subsequently expressed in the nucleo-cytosol of the host and organelle-targeted via the acquisition of N-terminal presequences, whose evolutionary origin remains enigmatic. Using a quantitative assessment of their physico-chemical properties, we show that organelle targeting peptides, which are distinct from signal peptides targeting other subcellular compartments, group with a subset of antimicrobial peptides. We demonstrate that extant antimicrobial peptides target a fluorescent reporter to either the mitochondria or the chloroplast in the green alga Chlamydomonas reinhardtii and, conversely, that extant targeting peptides still display antimicrobial activity. Thus, we provide strong computational and functional evidence for an evolutionary link between organelle-targeting and antimicrobial peptides. Our results support the view that resistance of bacterial progenitors of organelles to the attack of host antimicrobial peptides has been instrumental in eukaryogenesis and in the emergence of photosynthetic eukaryotes. Keywords: Chlamydomonas; targeting peptides; antimicrobial peptides; primary endosymbiosis; import into organelles; chloroplast; mitochondrion 1.
    [Show full text]
  • Magainin 2 in Action: Distinct Modes of Membrane Permeabilization in Living Bacterial and Mammalian Cells
    Biophysical Journal Volume 95 December 2008 5757–5765 5757 Magainin 2 in Action: Distinct Modes of Membrane Permeabilization in Living Bacterial and Mammalian Cells Yuichi Imura, Naoki Choda, and Katsumi Matsuzaki Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-Ku, Kyoto 606-8501, Japan ABSTRACT Interactions of cationic antimicrobial peptides with living bacterial and mammalian cells are little understood, although model membranes have been used extensively to elucidate how peptides permeabilize membranes. In this study, the interaction of F5W-magainin 2 (GIGKWLHSAKKFGKAFVGEIMNS), an equipotent analogue of magainin 2 isolated from the African clawed frog Xenopus laevis, with unfixed Bacillus megaterium and Chinese hamster ovary (CHO)-K1 cells was investigated, using confocal laser scanning microscopy. A small amount of tetramethylrhodamine-labeled F5W-magainin 2 was incorporated into the unlabeled peptide for imaging. The influx of fluorescent markers of various sizes into the cytosol revealed that magainin 2 permeabilized bacterial and mammalian membranes in significantly different ways. The peptide formed pores with a diameter of ;2.8 nm (, 6.6 nm) in B. megaterium, and translocated into the cytosol. In contrast, the peptide significantly perturbed the membrane of CHO-K1 cells, permitting the entry of a large molecule (diameter, .23 nm) into the cytosol, accompanied by membrane budding and lipid flip-flop, mainly accumulating in mitochondria and nuclei. Adenosine triphosphate and negatively charged glycosaminoglycans were little involved in the magainin-induced permeabilization of membranes in CHO-K1 cells. Furthermore, the susceptibility of CHO-K1 cells to magainin was found to be similar to that of erythrocytes. Thus, the distinct membrane-permeabilizing processes of magainin 2 in bacterial and mammalian cells were, to the best of our knowledge, visualized and characterized in detail for the first time.
    [Show full text]
  • A Molecular Dynamics Study of the Bee Venom Melittin in Aqueous Solution, in Methanol, and Inserted in a Phospholipid Bilayer
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by RERO DOC Digital Library Eur Biophys J (2006) 35: 255–267 DOI 10.1007/s00249-005-0033-7 ARTICLE Alice Gla¨ttli Æ Indira Chandrasekhar Wilfred F. van. Gunsteren A molecular dynamics study of the bee venom melittin in aqueous solution, in methanol, and inserted in a phospholipid bilayer Received: 27 June 2005 / Revised: 5 October 2005 / Accepted: 8 October 2005 / Published online: 2 December 2005 Ó EBSA 2005 Abstract The structural properties of melittin, a small increase in membrane permeability through disruption amphipathic peptide found in the bee venom, are of the packing of lipid molecules, which is called the investigated in three different environments by molecu- ‘‘carpet effect’’ [6, 7]. However, they may also reorient to lar dynamics simulation. Long simulations have been adopt an orientation perpendicular to the bilayer sur- performed for monomeric melittin solvated in water, in face, a so-called transmembrane orientation, and then methanol, and shorter ones for melittin inserted in a associate to form either barrel-stave pores [8] or toroidal dimyristoylphosphatidylcholine bilayer. The resulting pores [9, 10] within the bilayer causing size-selective trajectories were analysed in terms of structural prop- leakage and eventually membrane-lysis [4, 11]. The erties of the peptide and compared to the available mode and effectiveness of the disruption of the mem- NMR data. While in water and methanol solution me- brane barrier function depends on the one hand on the littin is observed to partly unfold, the peptide retains its peptide concentration and on the other hand on the structure when embedded in a lipid bilayer.
    [Show full text]
  • (Amps) and Their Delivery Strategies for Wound Infections
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 17 July 2020 doi:10.20944/preprints202007.0375.v1 Peer-reviewed version available at Pharmaceutics 2020, 12, 840; doi:10.3390/pharmaceutics12090840 1 Review 2 An Update on Antimicrobial Peptides (AMPs) and 3 Their Delivery Strategies for Wound Infections 4 Viorica Patrulea 1,2,*, Gerrit Borchard 1,2 and Olivier Jordan 1,2,* 5 1 University of Geneva, Institute of Pharmaceutical Sciences of Western Switzerland, 1 Rue Michel Servet, 6 1211 Geneva, Switzerland 7 2 University of Geneva, Section of Pharmaceutical Sciences, 1 Rue Michel Servet, 1211 Geneva, Switzerland 8 * Correspondence: [email protected]; Tel.: +41-22379-3323 (V.P.); [email protected]; Tel.: +41- 9 22379-6586 (O.J.) 10 11 Abstract: Bacterial infections occur when wound healing fails to reach the final stage of healing, 12 usually hindered by the presence of different pathogens. Different topical antimicrobial agents are 13 used to inhibit bacterial growth due to antibiotic failure in reaching the infected site accompanied 14 very often by an increased drug resistance and other side effects. In this review, we focus on 15 antimicrobial peptides (AMPs), especially those with a high potential of efficacy against multidrug- 16 resistant and biofilm-forming bacteria and fungi present in wound infections. Currently, different 17 AMPs undergo preclinical and clinical phase to combat infection-related diseases. AMP dendrimers 18 (AMPDs) have been mentioned as potent microbial agents. Various AMP delivery strategies, such as 19 polymers, scaffolds, films and wound dressings, organic and inorganic nanoparticles, to combat 20 infection and modulate the healing rate have been discussed as well.
    [Show full text]
  • The Structure of the Antimicrobial Human Cathelicidin LL-37 Shows
    www.nature.com/scientificreports OPEN The structure of the antimicrobial human cathelicidin LL‑37 shows oligomerization and channel formation in the presence of membrane mimics Enea Sancho‑Vaello1,7, David Gil‑Carton2, Patrice François 3, Eve‑Julie Bonetti3, Mohamed Kreir4,8, Karunakar Reddy Pothula 5, Ulrich Kleinekathöfer 5 & Kornelius Zeth6* The human cathelicidin LL‑37 serves a critical role in the innate immune system defending bacterial infections. LL‑37 can interact with molecules of the cell wall and perforate cytoplasmic membranes resulting in bacterial cell death. To test the interactions of LL‑37 and bacterial cell wall components we crystallized LL‑37 in the presence of detergents and obtained the structure of a narrow tetrameric channel with a strongly charged core. The formation of a tetramer was further studied by cross‑ linking in the presence of detergents and lipids. Using planar lipid membranes a small but defned conductivity of this channel could be demonstrated. Molecular dynamic simulations underline the stability of this channel in membranes and demonstrate pathways for the passage of water molecules. Time lapse studies of E. coli cells treated with LL‑37 show membrane discontinuities in the outer membrane followed by cell wall damage and cell death. Collectively, our results open a venue to the understanding of a novel AMP killing mechanism and allows the rational design of LL‑37 derivatives with enhanced bactericidal activity. Te increase in antibiotic resistance is one of the biggest health challenges our society is currently facing1. As a consequence, the discovery of new bactericidal drug candidates from any source including antimicrobial peptides (AMPs) is urgent2–4.
    [Show full text]
  • Cathelicidins: Family of Antimicrobial Peptides. a Review
    Mol Biol Rep (2012) 39:10957–10970 DOI 10.1007/s11033-012-1997-x Cathelicidins: family of antimicrobial peptides. A review Ewa M. Kos´ciuczuk • Paweł Lisowski • Justyna Jarczak • Nina Strzałkowska • Artur Jo´z´wik • Jarosław Horban´czuk • Jo´zef Krzyzewski_ • Lech Zwierzchowski • Emilia Bagnicka Received: 1 January 2012 / Accepted: 1 October 2012 / Published online: 14 October 2012 Ó The Author(s) 2012. This article is published with open access at Springerlink.com Abstract Cathelicidins are small, cationic, antimicrobial immune system in many vertebrates, including humans and peptides found in humans and other species, including farm farm animals. A lot of antimicrobial peptides (AMPs) are animals (cattle, horses, pigs, sheep, goats, chickens, rabbits stored in neutrophil and macrophage granules. They are part and in some species of fish). These proteolytically activated of the oxygen-independent activity against pathogens [1]. peptides are part of the innate immune system of many ver- The existence of the family of antimicrobial peptides named tebrates. These peptides show a broad spectrum of antimi- cathelicidins was established based on the presence of a crobial activity against bacteria, enveloped viruses and fungi. conserved cathelin domain. The first cathelicidin, cecropin, Apart from exerting direct antimicrobial effects, cathelicidins was isolated in 1980 from tissues of the Hyalophora can also trigger specific defense responses in the host. Their cecropia moth after a 10 year study on insect immunity [2]. roles in various pathophysiological conditions have been Another member of the cathelicidins family, magainin, was studied in mice and humans, but there are limited information isolated in 1987 by Zasloff from the skin of the Xenopus about their expression sites and activities in livestock.
    [Show full text]
  • Structure, Function, and Evolution of Gga-Avbd11, the Archetype of the Structural Avian-Double- Β-Defensin Family
    Structure, function, and evolution of Gga-AvBD11, the archetype of the structural avian-double- β-defensin family Nicolas Guyota, Hervé Meudalb, Sascha Trappc, Sophie Iochmannd, Anne Silvestrec, Guillaume Joussetb, Valérie Labase,f, Pascale Reverdiaud, Karine Lothb,g, Virginie Hervéd, Vincent Aucagneb, Agnès F. Delmasb, Sophie Rehault-Godberta,1, and Céline Landonb,1 aBiologie des Oiseaux et Aviculture, Institut National de la Recherche Agronomique, Université de Tours, 37380 Nouzilly, France; bCentre de Biophysique Moléculaire, CNRS, 45071 Orléans, France; cInfectiologie et Santé Publique, Institut National de la Recherche Agronomique, Université de Tours, 37380 Nouzilly, France; dCentre d’Etude des Pathologies Respiratoires, INSERM, Université de Tours, 37032 Tours, France; ePhysiologie de la Reproduction et des Comportements, Institut National de la Recherche Agronomique, CNRS, Institut Français du Cheval et de l’Equitation, Université de Tours 37380 Nouzilly, France; fPôle d’Analyse et d’Imagerie des Biomolécules, Chirurgie et Imagerie pour la Recherche et l’Enseignement, Institut National de la Recherche Agronomique, Centre Hospitalier Régional Universitaire, Université de Tours, 37380 Nouzilly, France; and gUnité de Formation et de Recherche Sciences et Techniques, Université d’Orléans, 45100 Orléans, France Edited by Akiko Iwasaki, Yale University, New Haven, CT, and approved November 26, 2019 (received for review July 26, 2019) Outofthe14avianβ-defensins identified in the Gallus gallus genome, The sequence of Gga-AvBD11 contains 2 predicted β-defensin only 3 are present in the chicken egg, including the egg-specific avian motifs (Fig. 1) (7) and represents the sole double-sized defensin β-defensin 11 (Gga-AvBD11). Given its specific localization and its (9.3 kDa) among all 14 AvBDs reported in the chicken species.
    [Show full text]
  • Status, Antimicrobial Mechanism, and Regulation of Natural Preservatives in Livestock Food Systems
    Korean J. Food Sci. An. Vol. 36, No. 4, pp. 547~557 (2016) DOI http://dx.doi.org/10.5851/kosfa.2016.36.4.547 © 2016 Korean Society for Food Science of Animal Resources ISSN 1225-8563 eISSN 2234-246X ARTICLE Status, Antimicrobial Mechanism, and Regulation of Natural Preservatives in Livestock Food Systems Na-Kyoung Lee1 and Hyun-Dong Paik1,2* 1Department of Food Science and Biotechnology of Animal Resources, Konkuk University, Seoul 05029, Korea 2Bio/Molecular Informatics Center, Konkuk University, Seoul 05029, Korea Abstract This review discusses the status, antimicrobial mechanisms, application, and regulation of natural preservatives in livestock food sys- tems. Conventional preservatives are synthetic chemical substances including nitrates/nitrites, sulfites, sodium benzoate, propyl gallate, and potassium sorbate. The use of artificial preservatives is being reconsidered because of concerns relating to headache, allergies, and cancer. As the demand for biopreservation in food systems has increased, new natural antimicrobial compounds of various origins are being developed, including plant-derived products (polyphenolics, essential oils, plant antimicrobial peptides (pAMPs)), animal-derived products (lysozymes, lactoperoxidase, lactoferrin, ovotransferrin, antimicrobial peptide (AMP), chitosan and others), and microbial metabolites (nisin, natamycin, pullulan, ε-polylysine, organic acid, and others). These natural preservatives act by inhibiting microbial cell walls/membranes, DNA/RNA replication and transcription, protein synthesis, and metabolism. Natural preservatives have been rec- ognized for their safety; however, these substances can influence color, smell, and toxicity in large amounts while being effective as a food preservative. Therefore, to evaluate the safety and toxicity of natural preservatives, various trials including combinations of other substances or different food preservation systems, and capsulation have been performed.
    [Show full text]